Cargando…
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
BACKGROUND: Previous research has examined patient perceptions of insulin injection devices. However, injectable medications other than insulin are increasingly used to treat type 2 diabetes, including GLP-1 receptor agonists. No patient-reported outcome (PRO) instruments have been developed taking...
Autores principales: | Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Paczkowski, Rosirene, Jordan, Jessica, Murray, Lindsey T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153258/ https://www.ncbi.nlm.nih.gov/pubmed/30294713 http://dx.doi.org/10.1186/s41687-018-0068-z |
Ejemplares similares
-
Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Matza, Louis S., et al.
Publicado: (2018) -
Validity and analysis of the Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Boye, Kristina S., et al.
Publicado: (2020) -
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2017) -
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S, et al.
Publicado: (2018) -
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
por: Gelhorn, Heather L, et al.
Publicado: (2015)